Jain Global’s Cytokinetics CYTK Stock Holding History

Jain Global’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,418	Closed	-$1.34M	–	1281
2025 Q3	$1.34M	Buy	+24,418	New	+$1.01M	0.01%	605

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Jain Global's CYTK Position: Q4 2025 in Review

Jain Global sold out of Cytokinetics (CYTK) in Q4 2025, closing a stake of 24,418 shares — an estimated $1.34M sold.

Jain Global first reported a position in CYTK in Q3 2025 and held it in 1 quarter. The position peaked at $1.34M in Q3 2025. 430 funds tracked by Wall St. Rank hold CYTK as of Q4 2025.

Jain Global reported no remaining Cytokinetics position as of Q4 2025 after selling out during the quarter.
Jain Global sold 24,418 Cytokinetics shares in Q4 2025, an estimated $1.34M.
Jain Global first reported a position in Cytokinetics in Q3 2025 and held it in 1 quarter.
Jain Global's Cytokinetics position peaked at $1.34M in Q3 2025.
430 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.